Progress in Research on the Surface/Interface of Materials for Hard Tissue Implant

doi:10.3724/SP.J.1077.2011.00001

Abstract

Abstract: The investigation of the surface/interface of hard tissue implant materials is very important for improving their properties and application. This paper reviews the research progress and tendency of studies on the surface/interface for hard tissue implant, especially on titanium and titanium alloys, based on the law of hard tissue implant. The improvement of the bone regeneration and antibacterial properties of titanium-based alloys by surface modification has become the hot topics in recent years. Generally, loading growth factors and coating bioactive ceramics onto the surfaces of titanium and its alloys are valid ways to improve their ability of bone regeneration. And loading antibiotics and antibacterial agents have been proven to be an effective method to improve the antibacterial property of titanium implant. With the development of nanotechnology and biotechnology as well as the innovation of surface modification technologies, it is expected that to obtain titanium implants with combining bone regeneration and antibacterial properties by the hybrid surface modification.

Key words: hard tissue, bone regeneration, antibacterial, titanium, surface/interface

CLC Number:

R318

LIU Xuan-Yong. Progress in Research on the Surface/Interface of Materials for Hard Tissue Implant[J]. Journal of Inorganic Materials, 2011, 26(1): 1-11.

References

[1] Jones F H. Teeth and bones: application of surface sciences to dental materials and related materials. Surf. Sci. R, 2001, 42(3/4/5): 75-205.

[2] Hench L L. Biomaterials. Science, 1980, 208(4446): 826-831.

[3] Hench L L, Wilson J. Surface-active biomaterials. Science, 1984, 226(4675): 630-636.

[4] Balasundaram G, Webster T J. A perspective on nanophase materials for orthopedic implant applications. J. Mater. Chem., 2006, 16(38): 3737-3745.

[5] Shi Z, Neoh K G, Kang E T, et al. Surface functionalization of titanium with carboxymethyl chitosan and immobilized bone morphogenetic protein-2 for enhanced osseointegration. Biomacromolecules, 2009, 10(6): 1603-1611.

[6] Hench L L, Polak J M. Third-generation biomedical materials. Science, 2002, 295(5557): 1014-1017.

[7] Leeuwenburgh S C G, Jansen J A, Malda J, et al. Trends in biomaterials research: an analysis of the scientific programme of the World Biomaterials Congress 2008. Biomaterials, 2008, 29(21): 3047-3052.

[8] Burns J W. Biology takes centre stage. Nat. Mater., 2009, 8(6): 441-443.

[9] Kirkpatrick C J, Fuchs S, Peters K, et al. Visions for regenerative medicine: interface between scientific fact and science fiction. Artif. Organs, 2006, 30(10): 822-827.

[10] 冯波, 翁杰, 屈树新, 等(FENG Bo, et al). 医用钛表面纳米结构化改性. 稀有金属材料与工程(Rare Metal Mat. Eng.,), 2007, 36(10): 1693-1697.

[11] Boyan B D, Kinney R C, Singh K, et al. Bone Morphogenetic Proteins and Other Bone Growth Factors, in Musculoskeletal Tissue Regeneration: Biological Materials and Methods. W.S. Pietrzak edited, Humana Press, 2008: 225-245

[12] Spagnoli A, Granero-Molto F, Weis J. Stem cells and fracture repair. Bone, 2009, 44(S1): S18-S55.

[13] Liu X, Chu P K, Ding C. Surface modification of titanium, titanium alloys, and related materials for biomedical applications. Mater. Sci. Eng. R, 2004, 47(3/4): 49-121.

[14] Storrie H, Stupp S I. Cellular response to zinc-containing organoapatite: an in vitro study of proliferation, alkaline phosphatase activityand biomineralization. Biomaterials, 2005, 26(27): 5492-5499.

[15] Alkhraisat M H, Moseke C, Blanco L, et al. Strontium modified biocements with zero order release kinetics. Biomaterials, 2008, 29(35): 4691-4697.

[16] Luthen F, Bulnheim U, Muller P D, et al. Influence of manganese ions on cellular behavior of human osteoblasts in vitro. Biomol. Eng., 2007, 24(5): 531-536.

[17] Amelio P D, Cristofaro M A, Tamone C, et al. Role of iron metabolism and oxidative damage in postmenopausal bone loss. Bone, 2008, 43(6): 1010-1015.

[18] 张方晨, 刘浩宇, 刘锡仪. 骨的微量元素代谢. 广东微量元素科学, 2005, 12(1): 1-7.

[19] Ebert R, Jakob F. Selenium Deficiency as a Putative Risk Factor for Osteoporosis. International Congress Series, 2007, 1297: 158-164.

[20] Inoue K, Matsuda K, Itoh M, et al. Osteopenia and male-specific sudden cardiac death in mice lacking a zinc transporter gene, Znt5. Hum. Mol. Genet., 2002, 11(15): 1775-1784.

[21] Fahmy M A, Hassan N H A, Farghaly A A, et al. Studies on the genotoxic effect of beryllium chloride and the possible protective role of selenium/vitamins A, C and E. Mut. Res., 2008, 652(2): 103-111.

[22] Shi Z, Neoh K G, Kang E T, et al. Titanium with surface-grafted dextran and immobilized bone morphogenetic protein-2 for inhibition of bacterial adhesion and enhancement of osteoblast functions. Tissue Eng. A, 2009, 15(2): 417-426.

[23] Hu J F, Garo E, Goering M G, et al. Bacterial biofilm inhibitors from diospyros dendo. J. Nat. Prod., 2006, 69(1): 118-120.

[24] Hetrick E M, Shin J H, Paul H S, et al. Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles. Biomaterials, 2009, 30(14): 2782-2789.

[25] Wan Y Z, Raman S, He F, et al. Surface modification of medical metals by ion implantation of silver and copper. Vacuum, 2007, 81(9): 1114-1118.

[26] WanY Z, Xiong G Y, Luo H L, et al. Influence of zinc ion implantation on surface nanomechanical performance and corrosion resistance of biomedical magnesium–calcium alloys. Appl. Surf. Sci., 2008, 254(17): 5514-5516.

[27] Hetrick E M, Schoenfisch M H. Reducing implant-related infections: active release strategies. Chem. Soc. Rev., 2006, 35(9): 780-789.

[28] Johannsson B, Callaghan J J. Prosthetic hip infection due to cryptococcus neoformans: case report. Diagn. Micro. Infec. Dis., 2009, 64(1): 76-79.

[29] Ochoa R A T, Mow C S. Deep infection of a total knee implant as a complication of disseminated pneumococcal sepsis: a case report and review of literature. The Knee, 2008, 15(2): 144-147.

[30] Brady R A, Calhoun J H, Leid J G, et al. Infections of Orthopaedic Implants and Devices. In: Shirtliff M, Leid J G, Springer series on biofilms V3. Berlin Heidelberg: Springer-Verlag, 2009: 15-55.

[31] Mahomed N N, Barrett J A, Katz J N, et al. Rates and outcomes of primary and revision total hip replacement in the United States Medicare population. J. Bone Joint Surg. Am., 2003, 85A(1): 27-32.

[32] Ridgeway S, Wilson J, Charlet A, et al. Infection of the surgical site after arthroplasty of the hip. J. Bone Joint Surg. Br., 2005, 87(6): 844-850.

[33] Kelm J, Schmitt E, Anagnostakos K. Vacuum-assisted closure in the treatment of early hip joint infections. Int. J. Med. Sci., 2009, 6(5): 241-246

[34] Segawa H, Tsukayama D T, Kyle R F, et al. Infection after total knee arthroplasty. J. Bone Joint Surg. Am., 1999, 81(10): 1434-1445.

[35] Mahomed N N, Barrett J, Katz J N, et al. Epidemiology of total knee replacement in the United States Medicare population. J. Bone Joint Surg. Am., 2005, 87(6): 1222-1228.

[36] Carlile G S, Elvy J, Toms A D. Salmonella infection of a total knee replacement. The Knee, 2010, 17(5): 356-358.

[37] Meehan J, Jamal A A, Nguyen H. Prophylactic antibiotics in hip and knee arthroplasty. J. Bone Joint Surg. Am., 2009, 91(10): 2480-2490.

[38] Lantry J M, Roberts C S, Giannoudis P V. Operative treatment of scapular fractures: a systematic review. Injury, 2008, 39(3): 271-283.

[39] Cheung E V, Sperling J W, Cofield R H. Infection associated with hematoma formation after shoulder arthroplasty. Clin. Orthop. Relat. Res., 2008, 466(6):1363-1367.

[40] Randelli P, Castagna A, Cabitza F, et al. Infectious and thromboembolic complications of arthroscopic shoulder surgery. J. Shoulder Elbow Surg., 2010, 19(1): 97-101.

[41] Linberg C J, Sperling J W, Schleck C D, et al. Shoulder arthroplasty in morbidly obese patients. J. Shoulder Elbow Surg., 2009, 18(6): 903-906.

[42] Iyengar K P, Gudena R, Chitgopkar S D, et al. Primary septic arthritis of the acromio-clavicular joint: case report and review of literature. Arch. Orthop. Trauma. Surg., 2009, 129(1): 83-86.

[43] Olsen M A, Nepple J J, Riew K D, et al. Risk factors for surgical site infection following orthopaedic spinal operations. J. Bone Joint Surg. Am., 2008, 90(1): 62-69.

[44] Olsen M A, Mayfield J, Lauryssen C, et al. Risk factors for surgical site infection in spinal surgery. J. Neurosurg., 2003, 98(S2): 149-155.

[45] Jeon D W, Chang B S, Jeung U O, et al. A case of postoperative tuberculous spondylitis with a bizarre course. Clin. Orthop. Surg., 2009, 1(1): 58-62.

[46] Nazhat S N, Young A M, Pratten J. Sterility and Infection. In: Narayan R, Biomedical Materials. New York: Springer, 2009: 239-260.

[47] Moriarty T F, Schlegel U, Perren S, et al. Infection in fracture fixation: can we influence infection rates through implant design. J. Mater. Sci: Mater. Med., 2010, 21(3): 1031-1035.

[48] Darouiche R O. Treatment of infections associated with surgical implants. N. Engl. J. Med., 2004, 350(14): 1422-1429.

[49]